Real World Characteristics and Perceived Efficacy of Peginterferon Beta-1A Compared with Other Platform Injectable Therapies Among MS Patients: Evidence in Five European Countries

Describe the demographic and disease characteristics of peginterferon beta-1a patients in a real world data set, and compare perceived effectiveness and quality of life of multiple sclerosis (MS) patients treated with peginterferon beta-1a versus other platform injectable therapies (IM interferon beta-1a, SC interferon beta-1a, interferon beta-1b, glatiramer acetate) in five European countries.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research